Medytox Participates in the International Master Course on Aging Science 'IMCAS 2025'
Jung Hyun-ho, CEO of Medytox, is giving a presentation at a discussion session held on the 31st of last month (local time) at the International Master Course on Aging Science (IMCAS World Congress 2025). Photo by Medytox
View original imageBiopharmaceutical company Medytox announced on the 4th that it attended the International Master Course on Aging Science (IMCAS World Congress 2025) held in Paris for three days from the 30th of last month to the 1st (local time).
IMCAS is a global aesthetic surgery conference where dermatologists, plastic surgeons, and industry professionals from around the world present the latest trends, technologies, and know-how and share insights. This year, about 18,000 industry participants from over 130 countries attended.
On the first day, Medytox held 'Medytox Night,' an ancillary event inviting partner companies from 17 countries. Until the last day, they discussed various measures to activate local sales through individual meetings with partners from each country. A total of 18 companies from Europe, the Middle East, and Latin America participated in the meetings, including Brazilian pharmaceutical company Blau Farmac?utica S.A., which signed a large-scale botulinum toxin supply contract with Medytox earlier last year. They exchanged opinions on future supply plans and marketing activities.
On the second day, the 31st, CEO Jeong Hyun-ho participated as a panelist in the 'La Tribune' session, discussing recent market trends and botulinum toxin strategies by type. He also revealed Medytox's plans to launch liquid botulinum toxin formulations and its overseas expansion strategies in the US, Europe, and other markets.
On the final day, through a lecture titled 'Botulinum Toxin Pipeline and Future,' Medytox showcased its established botulinum toxin product lineup and provided scientific information about products soon to be launched.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Less Than a Year Later... Eunma Apartment Reconstruction Payments Surge by 300 Million Won
- "Manhole Cover Blasts Open in 12 Seconds... The Reason Behind the 'Gangnam Flood Disaster' [Report]"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
A Medytox official stated, "Attending IMCAS, a world-renowned aesthetic surgery conference, was a great opportunity to introduce Medytox's diverse toxin products and demonstrate their excellence. We will do our best to successfully enter overseas markets based on our unique product capabilities."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!['WHO Declares International Public Health Emergency' Why the Untreatable 'Variant Ebola' Is More Deadly Than COVID-19 [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052110164072055_1779326201.png)
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
